BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8823377)

  • 1. CD59 homologue regulates complement-dependent cytolysis of rat Schwann cells.
    Sawant-Mane S; Piddlesden SJ; Morgan BP; Holers VM; Koski CL
    J Neuroimmunol; 1996 Sep; 69(1-2):63-71. PubMed ID: 8823377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
    Rollins SA; Zhao J; Ninomiya H; Sims PJ
    J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody of patients with Guillain-BarrĂ© syndrome mediates complement-dependent cytolysis of rat Schwann cells: susceptibility to cytolysis reflects Schwann cell phenotype.
    Sawant-Mane S; Estep A; Koski CL
    J Neuroimmunol; 1994 Jan; 49(1-2):145-52. PubMed ID: 8294552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD59 protects rat kidney from complement mediated injury in collaboration with crry.
    Watanabe M; Morita Y; Mizuno M; Nishikawa K; Yuzawa Y; Hotta N; Morgan BP; Okada N; Okada H; Matsuo S
    Kidney Int; 2000 Oct; 58(4):1569-79. PubMed ID: 11012891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum-resistant strains of Borrelia burgdorferi evade complement-mediated killing by expressing a CD59-like complement inhibitory molecule.
    Pausa M; Pellis V; Cinco M; Giulianini PG; Presani G; Perticarari S; Murgia R; Tedesco F
    J Immunol; 2003 Mar; 170(6):3214-22. PubMed ID: 12626580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteins.
    Koski CL; Estep AE; Sawant-Mane S; Shin ML; Highbarger L; Hansch GM
    J Neurochem; 1996 Jan; 66(1):303-12. PubMed ID: 8522968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of human and rat CD59 to the terminal complement complexes.
    Lehto T; Morgan BP; Meri S
    Immunology; 1997 Jan; 90(1):121-8. PubMed ID: 9038722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
    Rollins SA; Sims PJ
    J Immunol; 1990 May; 144(9):3478-83. PubMed ID: 1691760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of rat complement control protein Crry on tumor cells inhibits rat natural killer cell-mediated cytotoxicity.
    Caragine TA; Imai M; Frey AB; Tomlinson S
    Blood; 2002 Nov; 100(9):3304-10. PubMed ID: 12384431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative complement pathway-mediated myeloid cell cytotoxicity: repertoire of membrane factors participating in regulation of C3 deposition and cytolysis.
    Matsumoto M; Sugita Y; Seya T
    Eur J Immunol; 1991 Aug; 21(8):1787-92. PubMed ID: 1714391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human complement regulatory protein CD59 binds to the alpha-chain of C8 and to the "b"domain of C9.
    Ninomiya H; Sims PJ
    J Biol Chem; 1992 Jul; 267(19):13675-80. PubMed ID: 1377690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8.
    Lehto T; Meri S
    J Immunol; 1993 Nov; 151(9):4941-9. PubMed ID: 7691959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex.
    Kochi SK; Johnson RC; Dalmasso AP
    J Immunol; 1991 Jun; 146(11):3964-70. PubMed ID: 2033266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific collaboration between rat membrane complement regulators Crry and CD59 protects peritoneum from damage by autologous complement activation.
    Mizuno T; Mizuno M; Morgan BP; Noda Y; Yamada K; Okada N; Yuzawa Y; Matsuo S; Ito Y
    Nephrol Dial Transplant; 2011 Jun; 26(6):1821-30. PubMed ID: 21098015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of the ratio of the eighth and ninth components of human complement on complement-lysed membranes.
    Stewart JL; Monahan JB; Brickner A; Sodetz JM
    Biochemistry; 1984 Aug; 23(18):4016-22. PubMed ID: 6487588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9.
    Farkas I; Baranyi L; Ishikawa Y; Okada N; Bohata C; Budai D; Fukuda A; Imai M; Okada H
    J Physiol; 2002 Mar; 539(Pt 2):537-45. PubMed ID: 11882685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement regulation in the rat glomerulus: Crry and CD59 regulate complement in glomerular mesangial and endothelial cells.
    Quigg RJ; Morgan BP; Holers VM; Adler S; Sneed AE; Lo CF
    Kidney Int; 1995 Aug; 48(2):412-21. PubMed ID: 7564108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of complement regulatory proteins (CRPs) exacerbates experimental autoimmune anterior uveitis (EAAU).
    Jha P; Sohn JH; Xu Q; Wang Y; Kaplan HJ; Bora PS; Bora NS
    J Immunol; 2006 Jun; 176(12):7221-31. PubMed ID: 16751365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement pores in erythrocyte membranes. Analysis of C8/C9 binding required for functional membrane damage.
    Sims PJ
    Biochim Biophys Acta; 1983 Aug; 732(3):541-52. PubMed ID: 6871214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.